Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide vs Insulin Glargine in T2DM Patients on Metformin
NCT02325960Phase 4Completed
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jan 2015
- Primary completion
- Jul 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by Nanjing Drum-Tower Hospital. Started Jan 2015; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02325960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02325960.